Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Biopsy Devices Market

  • MAR2978949
  • 184 Pages
  • September 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
The Global Biopsy Devices Market was valued at US$ XX billion in 2016 and is expected to grow at around XX% CAGR to reach nearly US$ XX billion by 2022. Biopsy devices are devices that help to extract tissue samples from a patient's body and examine the samples to detect the presence or extent of diseases. Biopsies are mainly performed to detect whether a tissue sample is cancerous or not, although they may also be performed to detect other rare diseases. Biopsy devices may be of different types like biopsy needles, biopsy guidance systems, biopsy punches, and others. Growing incidence of diseases like cancer and increasing accessibility to healthcare are the main growth drivers of the global biopsy devices market.

End Users

End users of biopsy devices are mainly hospitals, diagnostic centres and medical clinics. Hospitals and medical clinics usually require biopsy devices for both extraction and examination of patient tissue samples. Diagnostic centres usually require biopsy devices that help to examine patient tissue samples and diagnose the associated medical condition.

Market Dynamics

One of the most important growth drivers for the global biopsy devices market is the increasing incidence of diseases like cancer. Greater accessibility to healthcare has enabled more number of people who experience cancer-like symptoms to avail of diagnostic tests, hence expanding the size of the market. Biopsy devices that ensure minimally invasive and pain-free procedures have attracted the largest share of the market. Other factors that are fuelling growth of the market are increased awareness about importance of proper diagnosis, increase in the geriatric population, increase in disposable incomes, and adoption of advanced technology.

A significant constraint in the expansion of the market is the relatively higher cost of biopsy procedures and the associated biopsy devices. Other factors that threaten the growth of the market are stringent government regulations, lack of availability of highly skilled technicians to run the biopsy devices, and development of other diagnostic processes that do not require extraction of tissue sample to detect the presence of diseases.

Market Segmentation

The global biopsy devices market can be segmented based on type of biopsy device, type of biopsy performed, end users, and geography. Based on type of biopsy device, the market can be segmented as biopsy needles, biopsy guns, robotic biopsy devices, guided biopsy devices, biopsy punches, and others. Based on type of biopsy performed, the market can be segmented as bone marrow biopsy devices, endoscopic biopsy devices, surgical biopsy devices, skin biopsy devices, and others. Based on end customers, the market can be segmented as hospitals, diagnostic centres and medical clinics.

Regional/Geographic Analysis

Geographically, the global biopsy devices market can be divided into North America, Europe, Asia-Pacific (APAC), and Latin America, Middle East and Africa (LAMEA) regions. Currently North America accounts for the largest share of the market. However, there is considerable growth potential in the APAC region due to high population, increasing incidence of diseases and increase in disposable incomes.

Key Players

Some of the major players in the market are Becton, Dickinson and Company, B. Braun Melsungen AG, Argon Medical Inc., Cook Medical, and others.

The report contains comprehensive analysis on:

--> Biopsy Devices Market Segments

--> Biopsy Devices Market Drivers, Restraints and Opportunities

--> Biopsy Devices Market Size & Forecast 2016 to 2022

--> Supply & Demand Value Chain

--> Biopsy Devices Market Current Trends

--> Competition &Major Companies

--> Technology and R&D Status

--> Porters Five Force Analysis

--> Strategic and Critical Success Factor Analysis of Key Players

Regional analysis for Biopsy Devices Market includes

--> North America

>> US and Canada

--> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

--> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

--> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

--> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

--> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.

Report Highlights::

--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

--> Consumer and Pricing Analysis

--> Market dynamics of the industry

--> In-depth Market Segmentation

--> Historical and Projected Market Sizing in terms of volume and value

--> Recent market trends and Impact Factors

--> R&D Status and Technology Overview

--> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390